TCRX
TScan TherapeuticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
TCRX Profile
Tscan Therapeutics, Inc.
A preclinical-stage biopharmaceutical company that developing T cell receptor engineered T cell therapies for the treatment of cancer
830 Winter Street, Waltham, Massachusetts 02451
--
TScan Therapeutics, Inc., was incorporated in Delaware on April 17, 2018. The company is a preclinical stage biopharmaceutical company focused on developing powerful T cell receptor engineered T cells or TCR-T therapies for the treatment of cancer patients.
